Anti‐B4‐blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma

This publication has 25 references indexed in Scilit:

• Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
  Blood, 1995
• Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
  Blood, 1995
• A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells
  Journal of Immunological Methods, 1994
• The Treatment of Multiple Myeloma
  New England Journal of Medicine, 1994
• The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
  The Journal of Experimental Medicine, 1993
• Restricted Expression of Immunoglobulin Light Chain mRNA and of the Adhesion Molecule CD11b on Circulating Monoclonal B Lineage Cells in Peripheral Blood of Myeloma Patients
  Scandinavian Journal of Immunology, 1992
• Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo
  European Journal of Immunology, 1992
• The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides
  Biochemistry, 1991
• Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.
  The Journal of Experimental Medicine, 1990
• Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis
  Journal of Cellular Physiology, 1989